Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2022-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$237.8m reported value
14positions
92.1%in top 10
—no comparable previous quarter

Options: 0 call positions (— notional), 1 put positions ($39.7m notional) – listed below, not included above.

Holdings, Q3 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 1,218,515 $40.3m16.94% 16.94% —
2 BLUEPRINT MEDICINES CORP COM BPMC BPMC 524,268 $34.5m14.53% 14.53% —
3 MERUS N V COM MRUS MRUS 1,507,109 $30.2m12.70% 12.70% —
4 ARVINAS INC COM ARVN ARVN 671,745 $29.9m12.57% 12.57% —
5 REGENXBIO INC COM RGNX RGNX 967,684 $25.6m10.76% 10.76% —
6 UNIQURE NV SHS QURE QURE 841,471 $15.8m6.64% 6.64% —
7 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 1,998,993 $13.8m5.82% 5.82% —
8 SILENCE THERAPEUTICS PLC ADS SLN SLN 1,263,125 $12.7m5.33% 5.33% —
9 ARGENX SE SPONSORED ADR ARGX ARGX 24,000 $8.5m3.56% 3.56% —
10 GENMAB A/S SPONSORED ADS GMAB GMAB 244,848 $7.9m3.31% 3.31% —
11 KYMERA THERAPEUTICS INC COM KYMR KYMR 330,246 $7.2m3.02% 3.02% —
12 SPERO THERAPEUTICS INC COM SPRO SPRO 3,403,210 $6.8m2.86% 2.86% —
13 PIERIS PHARMACEUTICALS INC COM COM 4,036,280 $4.6m1.95% 1.95% —
14 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 3,573 $29.0k0.01% 0.01% —

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 500,000 $39.7m500.0k shares —

Trades reported as a company insider in Q3 2022

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2022-09-22 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Sold 1,901,796 $4.3m1.9m shares -36%